Victory Capital Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,339
| Closed | -$3.56K | – | 2527 |
|
|
2025
Q1 | $3.56K | Sell |
10,339
-368
| -3% | -$127 | ﹤0.01% | 2470 |
|
|
2024
Q4 | $15.3K | Sell |
10,707
-751
| -7% | -$1.07K | ﹤0.01% | 2457 |
|
|
2024
Q3 | $21.7K | Sell |
11,458
-415
| -3% | -$784 | ﹤0.01% | 2435 |
|
|
2024
Q2 | $23.9K | Sell |
11,873
-214
| -2% | -$430 | ﹤0.01% | 2420 |
|
|
2024
Q1 | $54.2K | Sell |
12,087
-645
| -5% | -$2.89K | ﹤0.01% | 2369 |
|
|
2023
Q4 | $29.5K | Buy |
+12,732
| New | +$29.5K | ﹤0.01% | 2480 |
|
|
2022
Q3 | – | Sell |
-12,537
| Closed | -$58K | – | 2744 |
|
|
2022
Q2 | $58K | Buy |
12,537
+2,275
| +22% | +$10.5K | ﹤0.01% | 2535 |
|
|
2022
Q1 | $36K | Buy |
+10,262
| New | +$36K | ﹤0.01% | 2616 |
|
|
2021
Q2 | – | Sell |
-18,877
| Closed | -$305K | – | 2796 |
|
|
2021
Q1 | $305K | Sell |
18,877
-10,670
| -36% | -$172K | ﹤0.01% | 2388 |
|
|
2020
Q4 | $786K | Buy |
29,547
+10,084
| +52% | +$268K | ﹤0.01% | 1886 |
|
|
2020
Q3 | $362K | Buy |
19,463
+10,345
| +113% | +$192K | ﹤0.01% | 2093 |
|
|
2020
Q2 | $213K | Sell |
9,118
-1,900
| -17% | -$44.4K | ﹤0.01% | 2279 |
|
|
2020
Q1 | $64K | Buy |
+11,018
| New | +$64K | ﹤0.01% | 2669 |
|
|
2019
Q4 | – | Sell |
-6,444
| Closed | -$10K | – | 3018 |
|
|
2019
Q3 | $10K | Buy |
+6,444
| New | +$10K | ﹤0.01% | 3260 |
|
|
2018
Q1 | – | Sell |
-57,930
| Closed | -$952K | – | 1880 |
|
|
2017
Q4 | $952K | Buy |
57,930
+5,730
| +11% | +$94.2K | ﹤0.01% | 1231 |
|
|
2017
Q3 | $903K | Sell |
52,200
-1,800
| -3% | -$31.1K | ﹤0.01% | 1230 |
|
|
2017
Q2 | $754K | Buy |
+54,000
| New | +$754K | ﹤0.01% | 1240 |
|